UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis

Journal of the American Academy of Dermatology, 2007-04, Vol.56 (4), p.598-603

2007

Volltextzugriff (PDF)

Differences in binding and effector functions between classes of TNF antagonists

Cytokine (Philadelphia, Pa.), 2009-02, Vol.45 (2), p.124-131

2009

Volltextzugriff (PDF)

Binding Characteristics of Tumor Necrosis Factor Receptor-Fc Fusion Proteins vs Anti-Tumor Necrosis Factor mAbs

The Journal of investigative dermatology symposium proceedings, 2007-05, Vol.12 (1), p.5-8

2007

Volltextzugriff (PDF)

Etanercept for the treatment of psoriasis in the elderly

Journal of the American Academy of Dermatology, 2006-09, Vol.55 (3), p.517-519

2006

Volltextzugriff (PDF)

What have we learned in dermatology from the biologic therapies?

Journal of the American Academy of Dermatology, 2006-03, Vol.54 (3), p.S143-S151

2006

Volltextzugriff (PDF)

Patient-Reported Outcomes and Health-Care Resource Utilization in Patients with Psoriasis Treated with Etanercept: Continuous versus Interrupted Treatment

Value in health, 2008-05, Vol.11 (3), p.400-407

2008

Volltextzugriff (PDF)

Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists' offices

The Journal of dermatological treatment, 2006, Vol.17 (5), p.279-287

2006

Volltextzugriff (PDF)

Consensus conference on pediatric atopic dermatitis

Journal of the American Academy of Dermatology, 2003-12, Vol.49 (6), p.1088-1095

2003

Volltextzugriff (PDF)

Topical application of green and white tea extracts provides protection from solar-simulated ultraviolet light in human skin

Experimental dermatology, 2009-06, Vol.18 (6), p.522-526

2009

Volltextzugriff (PDF)

Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides–type cutaneous T-cell lymphoma

Journal of the American Academy of Dermatology, 2007-04, Vol.56 (4), p.635-642

2007

Volltextzugriff (PDF)

Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes

Journal of drugs in dermatology, 2008-03, Vol.7 (3), p.245

2008

Volltextzugriff (PDF)

Cost of atopic dermatitis and eczema in the United States

Journal of the American Academy of Dermatology, 2002-03, Vol.46 (3), p.361-370

2002

Volltextzugriff (PDF)

Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential

Human pathology, 2003-06, Vol.34 (6), p.617-622

2003

Volltextzugriff (PDF)

Psoriasis treatment patterns: Results of a cross-sectional survey of dermatologists

Journal of the American Academy of Dermatology, 2008-06, Vol.58 (6), p.964-969

2008

Volltextzugriff (PDF)

Phototherapy for cutaneous T-cell lymphoma

Dermatologic therapy, 2003-12, Vol.16 (4), p.303-310

2003

Volltextzugriff (PDF)

Apoptosis Mechanisms Related to the Increased Sensitivity of Jurkat T-cells vs A431 Epidermoid Cells to Photodynamic Therapy with the Phthalocyanine Pc 4

Photochemistry and photobiology, 2008-03, Vol.84 (2), p.407-414

2008

Volltextzugriff (PDF)

High Ultraviolet A Protection Affords Greater Immune Protection Confirming that Ultraviolet A Contributes to Photoimmunosuppression in Humans

Journal of investigative dermatology, 2003-10, Vol.121 (4), p.869-875

2003

Volltextzugriff (PDF)

Preliminary clinical and pharmacologic investigation of photodynamic therapy with the silicon phthalocyanine photosensitizer pc 4 for primary or metastatic cutaneous cancers

Frontiers in oncology, 2011, Vol.1, p.14-14

2011

Volltextzugriff (PDF)

Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis

Journal of the American Academy of Dermatology, 2003-04, Vol.48 (4), p.553-563

2003

Volltextzugriff (PDF)

Atopic dermatitis: the role of recombinant interferon-gamma therapy

American journal of clinical dermatology, 2002, Vol.3 (3), p.175-183

2002

Volltextzugriff (PDF)

UV Protective Effects of DNA Repair Enzymes and RNA Lotion

Photochemistry and photobiology, 2008-01, Vol.84 (1), p.180-184

2008

Volltextzugriff (PDF)

Pathophysiology of atopic dermatitis

Clinics in dermatology, 2003-03, Vol.21 (2), p.116-121

2003

Volltextzugriff (PDF)

Use of etanercept for psoriatic arthritis in the dermatology clinic: The Experience Diagnosing, Understanding Care, and Treatment with Etanercept (EDUCATE) study

The Journal of dermatological treatment, 2006-01, Vol.17 (6), p.343-352

2006

Volltextzugriff (PDF)

Long-term effectiveness and safety of recombinant human interferon gamma therapy for atopic dermatitis despite unchanged serum IgE levels

Archives of dermatology (1960), 1998-07, Vol.134 (7), p.799

1998

Volltextzugriff (PDF)

Reductions in healthcare resource utilization in psoriatic arthritis patients receiving etanercept therapy: results from the educate trial

Journal of drugs in dermatology, 2007-03, Vol.6 (3), p.299

2007

Volltextzugriff (PDF)

1 – 25 von 209

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(184)
Mit Volltextzugriff
(161)

Publikationsform

Sprache

Englisch
(209)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasis

Differences in binding and effector functions between classes of TNF antagonists

Binding Characteristics of Tumor Necrosis Factor Receptor-Fc Fusion Proteins vs Anti-Tumor Necrosis Factor mAbs

Etanercept for the treatment of psoriasis in the elderly

What have we learned in dermatology from the biologic therapies?

Patient-Reported Outcomes and Health-Care Resource Utilization in Patients with Psoriasis Treated with Etanercept: Continuous versus Interrupted Treatment

Clinical characteristics of psoriatic arthritis and psoriasis in dermatologists' offices

Consensus conference on pediatric atopic dermatitis

Topical application of green and white tea extracts provides protection from solar-simulated ultraviolet light in human skin

Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides–type cutaneous T-cell lymphoma

Utilization of narrow-band ultraviolet light B therapy and etanercept for the treatment of psoriasis (UNITE): efficacy, safety, and patient-reported outcomes

Cost of atopic dermatitis and eczema in the United States

Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential

Psoriasis treatment patterns: Results of a cross-sectional survey of dermatologists

Phototherapy for cutaneous T-cell lymphoma

Apoptosis Mechanisms Related to the Increased Sensitivity of Jurkat T-cells vs A431 Epidermoid Cells to Photodynamic Therapy with the Phthalocyanine Pc 4

High Ultraviolet A Protection Affords Greater Immune Protection Confirming that Ultraviolet A Contributes to Photoimmunosuppression in Humans

Preliminary clinical and pharmacologic investigation of photodynamic therapy with the silicon phthalocyanine photosensitizer pc 4 for primary or metastatic cutaneous cancers

Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis

Atopic dermatitis: the role of recombinant interferon-gamma therapy

UV Protective Effects of DNA Repair Enzymes and RNA Lotion

Pathophysiology of atopic dermatitis

Use of etanercept for psoriatic arthritis in the dermatology clinic: The Experience Diagnosing, Understanding Care, and Treatment with Etanercept (EDUCATE) study

Long-term effectiveness and safety of recombinant human interferon gamma therapy for atopic dermatitis despite unchanged serum IgE levels

Reductions in healthcare resource utilization in psoriatic arthritis patients receiving etanercept therapy: results from the educate trial

Suchergebnisse filtern